ACC.

22 Sessions Included in ACC Anywhere

Electrophysiology

• Arrhythmias in Cancer Patients – The Why, The How and The What To Do
• JACC: Case Reports Da Vinci Corner: Translational Cardiac Anatomy of the Ventricles
• New Technology or Better Organization? Optimizing Arrhythmia Care in Individual Patients: Joint
Symposium of the Heart Rhythm Society and the American College of Cardiology
• It Takes A Team: Remote Monitoring of Cardiac Devices and Personal Wearables
• Sudden Unexplained Cardiac Arrest and Death: How Do I Evaluate the Patient and Family?
• Artificial Intelligence in Electrophysiology: Will Machines Replace Us?
• Stroke Prevention in Atrial Fibrillation
• Things You Should Know as a Female Interventional Cardiologist or Electrophysiologist
• Pacing Technologies
• AF in Older Adults: Should We Treat Them Differently?
• Return to Play: How to Manage the Return
• Sudden Death Risk 2022: It’s Not All About the LVEF
• Burning Controversies in Arrhythmia Care of Athletes
• Rapid-Fire ECG With the Experts
• Racial Disparities in Arrhythmia Management and Outcomes
• Atrial Fibrillation Across the Globe — A "Global Health Spoken Here" Session
• Core Knowledge in Action: To ICD or Not to ICD, That Is the Question
• EP Section Highlights
• Is the Rising Maternal Mortality In the US Due to Increased Arrhythmias?

Heart Failure and Cardiomyopathies

• Cardio-Oncology Program Building: Bridging the Gap Between the Heart and Cancer Care
• A Mother's Heart: A #SheForShe Symposium on Pregnancy and Heart Failure
• Hemodynamics 201: A Case-Based Approach to Heart Failure, Pulmonary Hypertension, and
Mechanical Circulatory Support
• Cardiac Amyloidosis: Challenges in Diagnosis and Management
• We Are Family: Utilizing the Multidisciplinary Heart Failure Team to Improve Transitions of Care
and Optimize Outpatient Therapy
• When You Hear Hoofbeats…The Zebra Cardiomyopathies
• Party Like It's 2022: The Latest Guidance in Heart Failure Care
 • #Trending Hot Topics: Internet Pop-Up Ads Versus Text Book Treatments for Heart Failure
Comorbidities
• Core Knowledge in Action: What Everyone Ought To Know About HF-rEF
• Not All Shock Is Created Equal: AMI Versus HF Cardiogenic Shock
• Twitter Me This: How Do #EPeeps and #HeartFunctionNotFailure Work Together?
• No Sugar For the Heart-An In-Depth Look at the Intersection of Diabetes and Heart Failure
• The Latest Hype in Hypertrophic Cardiomyopathy
• Riddle Me This: HFpEF Explained
• The Four Pillars of Guideline Directed Medical Therapy (GDMT) in Heart Failure Management —
The Tough Battle to Save More Lives Using Personalized Medicine: Joint Symposium of the Heart
Failure Society of America and the American College of Cardiology
• When Do I Need Help? Advanced Heart Failure Referral in 2022
• Perfect Is the Enemy of Good: How Best to Utilize Limited Resources in the Treatment of Heart
Failure Globally — A "Global Health Spoken Here" Session
• Traffic Report at the Intersection of Heart Failure and Structural Intervention
• Advances in Cardio-Oncology: From Bench to Bedside and Beyond!
• Guidelines and Beyond: Therapies for Advancing HFrEF
• Team of Teams: A Multidisciplinary Team-Based Approach to Cardiogenic Shock
• Novel Therapies in HFpEF: Drugs, Devices, and More
• "I Had COVID Months Ago, and I Still Get Winded and Tired": Persistent Cardiopulmonary
Limitations post-COVID
• Heart Failure Section Highlights
• Reparative Therapies for Heart Failure: Current Status in the Basic and Clinical Arenas
• Balancing the Scales for the A-B-C-Ds of Heart Failure Diversity

Interventional and Structural

• Cardiac Interventions and Pregnancy

• It’s Not Gruentzig's Cath Lab: New Technologies for Better PCI
• Complications: Let's Manage the Misery
• Antithrombotic Controversies in Structural Heart Disease
• Coronary CTO PCI: Everything You Need To Know
• Challenges in Management of Antithrombotic Therapy
• Complex PCI Potpourri
• Top Interventional Trials of 2021: April Madness
• Antithrombotic Management in Patients With Atrial Fibrillation Undergoing PCI
• The Pump Is In and the Hard Part Begins: Post-implantation Management in MCS
• Physiology and Imaging Guided Complex PCI in Daily Practice
• Core Knowledge in Action: Transcatheter Valve Intervention – Everything But the Aortic Valve
 • Pump the Jam (or Not?): Percutaneous Mechanical Circulatory Support
• Invasive Coronary Physiology in Acute Coronary Syndromes — A "Global Health Spoken Here"
Session
• Joint Symposium by the Society of Cardiovascular Angiography and Interventions and the
American College of Cardiology
• Practical Pearls for the Heart Team
• Complex Decision Making in Mitral Valve Disease: Joint Symposium of the Society of Thoracic
Surgeons and the American College of Cardiology
• Patient Selection for MCS: Are We Undertreating, Overtreating (or Both)?
• Trends and Updates in PAD
• Challenging Clinical Cases: The “Bread and Butter” and Beyond
• Fellows Bootcamp I: Old Kids on the Block — Current Hot Topics in PCI
• Fellows Bootcamp II: New Kids on the Block — Non-coronary Interventions
• New Physiology Assessment and Emerging Concepts to Guide in the Management of Patients
with Angina
• We're Late to the Party: Catching up on Late Presentation MI and Bridging the Gaps in
Disparities
• Building an Endovascular Practice
• Aortic Stenosis: Coronary Physiology and Advanced Ventricular Hemodynamics
• Pulmonary Embolism Treatment
• Don’t You Forget About Me: Updates in Non-Valvular Structural Heart Interventions
• Real World Impact of Innovative Interventional Technology
• Bleeding Reduction Strategies Following PCI
• TAVR: Clinical Controversies and Dilemmas
• How to Improve Outcomes for Critical Limb Ischemia
• State of the Art: MV and TV Therapies in 2022

Ischemic Heart Disease

• Pharmacologic and Lifestyle Management for ISHD: Why Disparities in Care Matter
• Turning Up Telehealth: Opportunities for Growth in Today’s Telehealth Care
• Oh My! MI in Pregnancy!! Risks, Diagnosis and Management of Pregnancy-associated
Myocardial Infarction and Ischemia
• Core Knowledge in Action: What Are the Current Recommendations for Risk Stratification of
Non-cardiac Surgery Patients?
• Challenges in STEMI Management in 2022
• Advancing Systems of Care For ST-Elevation Myocardial Infarction — A "Global Health Spoken
Here" Session
• Left Main Revascularization: A Practical Approach
 • Current Approaches to Antiplatelet Therapy for PCI in ACS & SIHD
• Cardiogenic Shock: Progress, Paradigms and Unresolved Problems
• Sticky Situations in Revascularization
• It's On Us—Incorporating Social Determinants of Health Into Our Daily Care of Patients with
Ischemic Heart Disease
• ASCVD Risk Factors and Beyond
• Dissecting the Data: Discussions on the Management of SCAD
• Peri-operative Care for Non-Cardiac Surgery: Emerging Strategies and Ongoing Controversies
• What’s in a Name? The Diagnosis, Treatment and Future of INOCA and MINOCA
• Advances in Cardiac Rehabilitation—Not Your Same Old Same Old
• What's Age Got to Do With It? Optimal Management of Coronary Artery Disease in the Very Old
• Alternative Therapies for Ischemic Heart Disease: Are They Really Complementary?
• Chest Pain in ED Decision Pathway
• Use and Misuse of High-sensitivity Troponin
• Guideline Update: Management of Acute Chest Pain
• Appraisal of the Revised AUC For Multimodality Imaging for SIHD
• Guideline Update: Management of Chronic Chest Pain
• Can Cardiac CT Do It ALL? The Emerging Role of Cardiac CT in Diagnosis and Management of CAD

Multimodality Imaging

• Sore, Hot, and At Risk: The Role of Multi-modality Imaging in Systemic Inflammatory Disease
• Imaging in EP Procedures: Smoke and Mirrors?
• IT'S ALIVE! Imaging for Viability: Established Modalities and New Ideas
• The Thick Heart, Role of Echocardiography: Joint Symposium of the American Society For
Echocardiography and the American College of Cardiology
• Advances in TTR Cardiac Amyloidosis Imaging
• It's Complicated! Challenging Structural Heart Disease Imaging Cases with Heart Team Panel
• Myocarditis in Competitive Athletes: Significance, Imaging Considerations, and COVID-19
Controversies
• Structural Heart Imaging for Transcatheter Valve Intervention: The Basics and Beyond
• Artificial Intelligence and Machine Learning in Cardiovascular Imaging
• COVID-19: Imaging the Cardiovascular System 2022 a Global Perspective — A "Global Health
Spoken Here" Session
• High Value, High Volume Cardiac MRI: What Is Your Practice Missing to Transform Care? Joint
Symposium of the Society For Cardiovascular Magnetic Resonance and the American College of
Cardiology
• How Do I Match Cardiac Imaging With the Cancer Therapeutics: Timely Diagnosis of CV Toxicities
 • Contemporary Clinical Topics in Cardiovascular CT: Joint Symposium of the Society of
Cardiovascular Computed Tomography and the American College of Cardiology
• Expanding the Boundaries of Nuclear Cardiology in 2022: Joint Symposium of the American
Society of Nuclear Cardiology and the American College of Cardiology
• Ongoing Controversies After the New Chest Pain Guidelines
• Role of Multimodality Imaging in Cardiac Sarcoidosis
• Myocardial Infarction With No Obstructive CAD (MINOCA) and Ischemia With No Obstructive
CAD (INOCA): Myth or Reality in Imaging

Pediatric and Congenital Heart Disease

• Playground Knowledge Drop: Moments That Defined My Career

• Multimodality Imaging and Team Decision-Making in Congenital Heart Disease
• When the Data Is Lacking: Debates in Arrhythmia Management in Pediatric and Congenital Heart
Disease
• Around the World for Pediatric and Congenital Heart Disease Care: What We Can Learn From
Each Other — A "Global Health Spoken Here" Session
• Congenitally Corrected TGA: From Fetus to Adulthood, Which Way Do We Go?
• Innovations in Treatment of Congenital Heart Disease
• Non-cardiac Disease in Congenital Heart Disease Across the Lifespan: Are We Missing
Something?
• Valve Therapy: The BEST Next Step on the Management of This Patient Is....
• Cardiac ICU: Team-based Approach to Complex Patients
• Challenges in Congenital Heart Management and Interventions: A Team Perspective
• Back to the Basics: Transforming Our Approach to Heart Failure
• Novel Team Collaborations Solving Challenges in Cardiac Care and Featuring the Dan G.
McNamara Keynote
• Individually, We Are One Drop. Together, We Are an Ocean: Optimizing Surgical Outcomes
Through Teamwork
• Heart Failure MCS in Children & Young Adults: Friend or Foe

Prevention and Health Promotion

• Innovations in Cardiac Rehab and Lifestyle Interventions

• Beyond Lifestyle: Next Steps in Obesity Management
• Early-Onset Myocardial Infarction with Normal LDL Cholesterol: Work-Up and Prevention
Featuring the 2022 Douglas P. Zipes Award Keynote
 • Hot Topics in Hypertension: Advancing Care to Increase Blood Pressure Control and Improve
Cardiovascular Outcomes
• Adventure Across the Lifespan — Dyslipidemia Management For the 21st Century: Joint
Symposium of the National Lipids Association and the American College of Cardiology
• Putting Out the Forest Fires: Management of Inflammation in Cardiovascular Disease
• Cardio-ObsteTRICKS = How Should a Pregnancy History Guide Promotion of CV Health
• Lowering LDL-C: New Goals, New Tools to Achieve Them
• The Global Burden of Hypertension: An International Session on Blood Pressure Control and
Cardiovascular Disease Prevention — A "Global Health Spoken Here" Session
• Triglyceride-Rich Lipoproteins: Mediator or Marker of Risk?
• Overcoming Real World Obstacles to Cardiovascular Prevention Globally
• Core Knowledge in Action: The ABCDEs of Heart Disease Prevention
• ABCD of Cardiovascular Prevention — Unanswered Questions and Unquestioned Answers: A 75-
minute Stateside Chat With Experts
• Finding the Sweet Spot for SGLT2 and GLP-1 Use in Cardiovascular Prevention
• Special Populations and Challenges in Lipid Management
• Lipoprotein(a) and HDL: Should We Pay Attention?
• Challenges in Hypertension Management: A Case Based Discussion with the Experts
• Chaat Masala: The Risk-Enhancing South Asian Ancestry
• Cardiometabolic Clinics: The Time Has Come
• Neurocardiology Collaborations in 2020's: Rationale, Goals and Prospects
• Prevention and Health Promotion Highlights

Pulmonary Vascular Disease

• What Would You Do? Managing Special Populations With Pulmonary Hypertension
• The Right Ventricle in Crisis: Pre-operative Evaluation and Management of the Critically Ill
Patient With Pulmonary Arterial Hypertension
• A Whole New World in Pulmonary Hypertension: Randomized Clinical Trial Updates For 2022
• Pulmonary Hypertension 101: A PH Primer for the General Cardiologist
• The Acquired Determinants of Disease in Pulmonary Arterial Hypertension — A "Global Health
Spoken Here" Session
• Back to the Future: Old Drugs With a New Purpose in PAH
Special Topics

• ACC.22 Opening Showcase

• Future of Peer-Reviewed Publishing From the JACC Journal Editors
• Emerging Cardiovascular Subspecialties From JACC: Advances
• Cardiovascular Research in Asian-Specific Populations: Lessons From JACC: Asia
• My Worst and Best Case Scenario from 2021 From JACC: Case Reports
• Clinical Cases Put Guidelines into Perspective From JACC: Case Reports
• The Role of Multidisciplinary Team From JACC: Case Reports
• Optimizing Your Research Tools – Exploring The Hypothesis Beyond Clinical Trials!
• Ethics in Cardiovascular Care
• Friends With Benefits (and Risks) How Can Industry Affect My Practice?
• Introduction Into AI and Machine Learning
• Best Practices in Parental Leave During Cardiology Fellowship
• Joint American College of Cardiology/Journal of the American College of Cardiology Late-
Breaking Clinical Trials
• Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking
Clinical Trials
• Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical
Trials
• Late-Breaking Clinical Trials IV
• Late-Breaking Clinical Trials V
• Featured Clinical Research I
• Featured Clinical Research II
• Featured Clinical Research III
• Late-Breaking Clinical Trials Deep Dive I
• Late-Breaking Clinical Trials Deep Dive II
• Lifestyle Medicine Intensive Session I: Moving Beyond Theory to Practice Featuring the 53rd
Annual Louis F. Bishop Keynote
• Lifestyle Medicine Intensive Session II: Moving Beyond Theory to Practice
• Cases From the Guidelines For Clinicians
• Cardiovascular Disease and Cognitive Impairment: What the Cardiovascular Provider Needs to
Remember
• The State of Cardiovascular Workforce: Global Insights and Solutions on Discrimination,
Harassment, and Racism
• Coronary Artery Disease – Atherogenesis, Acute Coronary Syndromes and Stroke: Cardiovascular
Update for the Clinician I, A Symposium by Valentin Fuster
• Myocardial Disease and Heart Failure – Imagenomics, Pharmacology and Devices:
Cardiovascular Update For the Clinician II, A Symposium by Valentin Fuster
• Electrical Disorders – Challenges in 2022: Cardiovascular Update For the Clinician III, A
Symposium by Valentin Fuster
• Structural Heart Disease – Challenges in 2022: Cardiovascular Update For the Clinician IV, A
Symposium by Valentin Fuster
• Pharmacology Session I: Anticoagulation and Device Management Strategies in Mechanical
Circulatory Support
• Pharmacology Session II: No Longer Failing to Treat Heart Failure — Optimizing Therapy With
Newer Pharmacologic Agents
• Pharmacology Session III: Cardiovascular Pharmacology Potpourri – From Weight Loss to Cardio
Oncology
• Role Models, Mentors, and Sponsors and Why We Need to Be All of Them
• Is the Quality of Cardiovascular Research Declining? What Research Should Continue to be
Pursued? Featuring the James T. Dove Keynote — A JACC Journals Session
• International Perspectives I: Seismic Changes in Novel Therapies For CVD Management and Risk
Reduction — Joint Symposium of the European Society of Cardiology and the American College
of Cardiology
• Promoting Cardiovascular Workforce Building and Resilience For Diverse Racial and Ethnic
Groups in Cardiovascular Medicine: Joint Symposium of the Association of Black Cardiologists
and the American College of Cardiology
• Bridging CV Quality Gaps Using Technology in Developing Healthcare Systems
• Renaissance in Hypertension Control: Is 130 Finally the New 140? Joint Symposium of the
American Heart Association and the American College of Cardiology
• Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Myocardial Involvement, Post-
acute Sequelae, and Return to Play
• The European Heart Journal's Year in Cardiovascular Medicine: Joint Symposium of the
European Society of Cardiology and the American College of Cardiology II
• Best of JACC Journals: Panel Discussion With the Editors
• 2022 Eugene Braunwald Keynote
• Shared Decision Making and Competitive Sporting Participation: How I Counsel My Athletic
Patient With Heart Disease
• Sports and Exercise Highlights
• 71st Annual Convocation
Valvular Heart Disease

• Mi TAVI Es Su TAVI? TAVI Around the World — A "Global Health Spoken Here" Session
• The Heart Valve Team: Good, Bad, and Ugly
• Controversies in Valvular Heart Disease — A Case-Based Approach: Joint Symposium of the
American Association For Thoracic Surgery and the American College of Cardiology
• Diagnosing Valvular Heart Disease: Throw Away Your Stethoscope!
• Treat the Whole Patient, Not Just the Valve
• Like A Rock: Conundrums in Calcific Mitral Valve Disease
• Procedural Planning for Valvular Heart Disease, a Focus on Mitral and Tricuspid Valves: The
Before and After
• Anticoagulation Agents in Valvular Heart Disease
• Mitral Regurgitation: Overview and Controversies
• Tricuspid Valve: The New Frontier
• Ethics and Resource Utilization in Valve Disease Intervention in Nonagenarians

Vascular Medicine

• Contemporary PAD Treatment: A Simplified Approach to A Complex Problem

• Diagnosis and Management of Aortic Disease
• Paging the PERT Team! Intermediate and High-Risk PE Cases With the Experts
• Vascular Medicine Consult: An Expert's Approach
• Addressing Health Disparities in Lower Extremity PAD
• Risk Stratification in PAD: Who Is the High Risk Patient? — A "Global Health Spoken Here"
Session